beta-alanine has been researched along with Health Care Associated Infection in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " All the adverse events were recorded." | 1.38 | [The clinical efficacy and safety of panipenem-betamipron in treatment of moderate to severe pulmonary infection]. ( , 2012) |
| " The pharmacokinetic parameters in these population are given below: CLPAPM; 0." | 1.31 | [Pharmacokinetics of panipenem in neonates and dosage recommendation]. ( Kimura, T; Kokubun, H; Matsuura, N; Nishisako, M; Nonoyama, M; Nowatari, M; Oguchi, K; Shimada, S; Sunakawa, K, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magee, TV | 1 |
| Brown, MF | 1 |
| Starr, JT | 1 |
| Ackley, DC | 1 |
| Abramite, JA | 1 |
| Aubrecht, J | 1 |
| Butler, A | 1 |
| Crandon, JL | 1 |
| Dib-Hajj, F | 1 |
| Flanagan, ME | 1 |
| Granskog, K | 1 |
| Hardink, JR | 1 |
| Huband, MD | 1 |
| Irvine, R | 1 |
| Kuhn, M | 1 |
| Leach, KL | 1 |
| Li, B | 1 |
| Lin, J | 1 |
| Luke, DR | 1 |
| MacVane, SH | 1 |
| Miller, AA | 1 |
| McCurdy, S | 1 |
| McKim, JM | 1 |
| Nicolau, DP | 1 |
| Nguyen, TT | 1 |
| Noe, MC | 1 |
| O'Donnell, JP | 1 |
| Seibel, SB | 1 |
| Shen, Y | 1 |
| Stepan, AF | 1 |
| Tomaras, AP | 1 |
| Wilga, PC | 1 |
| Zhang, L | 1 |
| Xu, J | 1 |
| Chen, JM | 1 |
| Kimura, T | 1 |
| Kokubun, H | 1 |
| Shimada, S | 1 |
| Nishisako, M | 1 |
| Nowatari, M | 1 |
| Oguchi, K | 1 |
| Matsuura, N | 1 |
| Nonoyama, M | 1 |
| Sunakawa, K | 1 |
3 other studies available for beta-alanine and Health Care Associated Infection
| Article | Year |
|---|---|
Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections.
Topics: Animals; Anti-Bacterial Agents; beta-Alanine; Cross Infection; Dogs; Drug Discovery; Drug Resistance | 2013 |
[The clinical efficacy and safety of panipenem-betamipron in treatment of moderate to severe pulmonary infection].
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Alanine; Community-Acquired Infections; Cross Infection; Dr | 2012 |
[Pharmacokinetics of panipenem in neonates and dosage recommendation].
Topics: Bacterial Infections; beta-Alanine; Cross Infection; Drug Administration Schedule; Drug Therapy, Com | 2000 |